Monday, August 15, 2022

Taysha Gene Therapies (NASDAQ:TSHA) PT Lowered to $32.00 at Chardan Capital

Taysha Gene Therapies, Inc, a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the ...
https://www.google.com/url?rct=j&sa=t&url=https://www.defenseworld.net/2022/08/15/taysha-gene-therapies-nasdaqtsha-pt-lowered-to-32-00-at-chardan-capital.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw23CGVQJFOfVv9oxBuUS-6c

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...